A further example is in the proto-oncogene c-myc, where in patients with multiple myeloma, a C > T substitution (NM_002467.6:c.577 C > T) within a reported IRES causes higher IRES activity and increased production of c-myc protein. This evidence concerns the gene MYC and plasma cell myeloma.